COMBO WCIO 5-25-2017pdf

Report 8 Downloads 348 Views
Combination  Therapies:  Quantifying  the  Effects  of  Transarterial  Embolization  on  Microwave   Ablation  Zones Erica  M.  Knavel,  M.D.,  Christopher  L.  Brace,  Ph.D.,  Paul  F.  Laeseke  M.D.,  Ph.D. Background

Figure 1. Procedural Images

There  is  increasing  interest  in  combining  transarterial  embolization  (TAE)  and  thermal  ablation  for  treating  large,  poorly  visualized,   or  infiltrative  hepatocellular  carcinomas. Improved  oncologic  outcomes  are  demonstrated  when  compared  with  either  therapy  alone  with  several  retrospective  studies   demonstrating  improved  overall  survival  (OS),  improved  recurrence-­free  survival  and  decreased  rate  of  disease  progression  with   combination  therapy  (TACE  combined  with  MW  or  RF  ablation)  compared  to  ablation  alone  for  the  treatment  of  HCC.1-­6

3

No  data  exists  regarding  the  effect  of  transarterial  embolization  on  the  size,  shape  and  reproducibility  of  subsequent  microwave ablations.    

4

2 1

The  purpose  of  this  study  is  to  quantify  the  effect  of  TAE  on  microwave  ablations  in  an  in  vivo porcine  liver  model.

Materials & Methods Femoral  arterial  approach  arteriograms  and  cone  beam  CT  scans  were  performed  to  delineate  hepatic  arterial  anatomy  and   identify  individual  branches  supplying  each  of  the  four  liver  lobes  in  6  female  domestic  swine.     Two  of  the  four  liver  lobes  were  embolized  to  near  stasis  (5  beat  stasis)  with  100-­300μm  Embosphere®  Microspheres  (Merit   Medical  Systems,  Inc.,  South  Jordan,  UT).   Microwave  ablations  (65  W,  5  min)  were  created  in  both  embolized  (TAE-­MW,  n=15)  and  non-­embolized  (MW,  n=  12)  portions  of   the  liver  using  a  2.45  GHz  system  and  single  antenna  (Certus  140  and  PR-­15,  NeuWave  Medical,  Inc.,  Madison  WI).   A  mixed  effects  model  was  used  to  compare  the  TAE-­MW  and  MW  groups.

Figure 2 :Ablation Temperatures

Table 1: Comparison of ablation zone metrics

Measurement

TAE  +  MW  Ablation

MW  Ablation

A.  Hepatic  arteriogram   demonstrating  porcine  anatomy:   1.  Right  Lateral  Branch   2.  Right  Medial  Branch   3.  Left  Medial  Branch   4.  Left  Lateral  Branch  

B.  Hepatic  arteriogram  following   bland  particle  embolization  of  the   Left  Medial  and  Left  Lateral   Branches  demonstrating  truncation   of  the  embolized  branches

Performing  TAE  prior  to  microwave  ablation  increases   ablation  zone  diameter  and  area  by  approximately   27%  and  66%,  respectively.  

A

*

P-­‐Value

11.8 ± 2.5

7.1 ± 1.9

<  0.0001

Length  (cm)

4.8 ± 0.5

3.7 ± 0.6

<  0.0001

Diameter  (cm)

3.1 ± 0.6

2.4 ± 0.3

0.0010

Central  Zone   Diameter  (cm)

1.7 ± 0.2

1.6 ± 0.2

0.2191

Peripheral  Zone   Width  (cm)

1.3 ± 0.4

0.8 ± 0.2

0.0007

Circularity

0.84 ± 0.06

0.83 ± 0.06

0.8942

D.  En  bloc  liver  specimen  demonstrating   post  embolization  changes  with  the   embolized  left  lobes  and  the  non  embolized   right  lobes

Discussion

Figure 3. Combination therapy vs. Ablation only

B

*

(n  =  7,  Mean  ± SD) (n  =  5,  Mean  ± SD) Area  (cm2)

C.  Cone  Beam  CT  confirming  positioning  of   left  medial  ablation  antenna  (arrowhead)   into  the  embolized  lobe  (delineated  by   retained  contrast  and  white  border)  and   placement  of  the  right  medial  ablation   antenna  (arrow)  in  the  non  embolized  lobe

This  size  increase  is  due  to  an  increase  in  the  size  of  the  peripheral  portion  of   the  ablation  zone,  which  is  most  susceptible  to  perfusion  mediated  cooling   and  heat  sinks.   Further  studies  are  warranted  to  characterize  the  effect  of  particle  size,  timing   of  the  embolization,  and  different  microwave  power/time  combinations  on  the   resultant  ablation  zones.

2  cm 2  cm

Mean  temperatures  recorded  1  cm  from  MW   antenna  during  two  control  MW  ablations  and  two   MW  ablations  performed  after  TAE.  Note  the  faster   heating  and  higher  maximum  temperatures   associated  with  MW  ablation  after  TAE.

A.  Combination  therapy  specimen  and   B.  MW  ablation  specimen  demonstrating   increased  total  size  and  increased  size  of  the  peripheral  non  charred  zone  (Asterisk)  of   sample  A  compared  to  sample  B.  The  charred  central  portion  (Triangle)  was  not   significantly  different  between  the  two  groups.

References 1.  Ni  JY,  Liu  SS,  Xu  LF,  Sun  HL,  Chen  YT.  Meta-­analysis  of  radiofrequency  ablation  in  combination  with  transarterial  chemoembolization  for  hepatocellular  carcinoma.   World  J  Gastroenterol.  2013;;19(24):3872-­82.   2.  Peng  ZW,  Zhang  YJ,  Chen  MS,  Xu  L,  Liang  HH,  Lin  XJ,  Guo  RP,  Zhang  YQ,  Lau  WY.  Radiofrequency  ablation  with  or  without  transcatheter  arterial   chemoembolization  in  the  treatment  of  hepatocellular  carcinoma:  a  prospective  randomized  trial.  J  Clin  Oncol. 2013;;31(4):426-­32. 3.  Yang  WZ,  Jiang  N,  Huang  N,  Huang  JY,  Zheng  QB,  Shen  Q.  Combined  therapy  with  transcatheter  arterial  chemoembolization  and  percutaneous  microwave   coagulation  for  small  hepatocellular  carcinoma.  World  J  Gastroenterol.  2009;;15(6):748-­52. 4.  Seki  T,  Tamai  T,  Nakagawa  T,  Imamura  M,  Nishimura  A,  Yamashiki  N,  Ikeda  K,  Inoue K.  Combination  therapy  with  transcatheter  arterial  chemoembolization  and   percutaneous microwave  coagulation  therapy  for  hepatocellular  carcinoma.  Cancer.  2000;;89(6):1245-­51. 5.  Li  W,  Man  W,  Guo  H,  Yang  P.  Clinical  study  of  transcatheter  arterial  chemoembolization  combined  with  microwave  ablation  in the  treatment  of  advanced   hepatocellular  carcinoma.  J  Cancer  Res  Ther.  2016;;12(Supplement):C217-­C20.   6.  Ginsburg  M,  Zivin  SP,  Wroblewski  K,  Doshi  T,  Vasnani  RJ,  Van  Ha  TG.  Comparison  of  Combination  Therapies  in  the  Management  of  Hepatocellular  Carcinoma:   Transarterial  Chemoembolization  with  Radiofrequency  Ablation  versus  Microwave  Ablation.  J  Vasc Interv  Radiol.  2015;;26(3):330-­41.